Boothbay Fund Management, LLC Synthetic Biologics, Inc. Transaction History

Boothbay Fund Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$4.5 - $7.1 $252,675 - $398,665	-56,150 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.7 - $6.1 $10,395 - $23,485	-3,850 Reduced 6.42%	56,150 $18,000
Q4 2018 Feb 14, 2019	BUY	$5.2 - $26.8 $312,000 - $1.61 Million	60,000 New	60,000 $34,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.